The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

Pfizer shares climbed Tuesday after two punchy headlines hit the wire. FDA advisors are considering COVID-19 vaccines for ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

The new framework unveiled May 20 says new COVID-19 shots should go only to those ages 65 and up or with underlying medical conditions.

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

Novavax's shot is now fully approved in the U.S. Since 2022, the vaccine has been used under an emergency use authorization.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...